![]() |
![]() |
Legal status
Patent revoked (after opposition at EPO)
(51) | INT.CL. | A61K 39/395 | (2006.01) |
A61K 31/4439 | (2006.01) | ||
A61K 31/198 | (2006.01) | ||
A61K 31/573 | (2006.01) | ||
A61K 31/69 | (2006.01) | ||
C07K 16/28 | (2006.01) | ||
A61K 9/10 | (2006.01) | ||
A61K 47/12 | (2006.01) | ||
A61K 47/20 | (2006.01) | ||
A61K 47/22 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 3370770 |
(13) | Kind of document | T |
(96) | European patent application number | 16862791.7 |
Date of filing the European patent application | 2016-11-01 | |
(97) | Date of publication of the European application | 2018-09-12 |
(45) | Date of publication and mention of the grant of the patent | 2021-01-20 |
(46) | Date of publication of the claims translation | 2021-04-12 |
(86) | Number | PCT/US2016/059893 |
Date | 2016-11-01 |
(87) | Number | WO 2017/079150 |
Date | 2017-05-11 |
(30) | Number | Date | Country code |
201562250016 P | 2015-11-03 | US |
(72) |
JANSSON, Richard, US
KUMAR, Vineet, US
|
(73) |
Janssen Biotech, Inc.,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Anti-CD38 antikūnų poodinės kompozicijos ir jų panaudojimas |
SUBCUTANEOUS FORMULATIONS OF ANTI-CD38 ANTIBODIES AND THEIR USES |
Payment date | Validity (years) | Amount | |
2024-10-04 | 9 | 208.00 EUR |
Patent revoked (after opposition at EPO) | ||
Invalidation date | 2025-01-22 |